Epstein—Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed—Sternberg cells
- 1 January 2000
- journal article
- Published by Elsevier BV in Annals of Oncology
- Vol. 11 (1), 91-96
- https://doi.org/10.1023/a:1008337100424
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's diseaseHistopathology, 2007
- Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international dataInternational Journal of Cancer, 1997
- Normal and malignant B-cell development with special reference to Hodgkin's diseaseAnnals of Oncology, 1997
- Epstein‐Barr virus in tumoursHistopathology, 1996
- Epidemiology of EBV and Hodgkin's lymphomaAnnals of Oncology, 1996
- A pathologic study of Hodgkin's disease in Korea and its association with the Epstein-Barr virus infectionCancer, 1996
- The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhoodAnnals of Hematology, 1994
- The association between epstein‐barr virus and chinese hodgkin's diseaseInternational Journal of Cancer, 1993
- Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's diseaseThe Journal of Pathology, 1992
- The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBVInternational Journal of Cancer, 1971